These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 35190459)

  • 1. Clinical research on COVID-19: perceptions and barriers to participation in The Gambia.
    Diallo BA; Usuf E; Ceesay O; D'Alessandro U; Roca A; Martinez-Alvarez M
    BMJ Glob Health; 2022 Feb; 7(2):. PubMed ID: 35190459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From informed consent to adherence: factors influencing involvement in mass drug administration with ivermectin for malaria elimination in The Gambia.
    Fehr A; Nieto-Sanchez C; Muela J; Jaiteh F; Ceesay O; Maneh E; Baldeh D; Achan J; Dabira E; Conteh B; Bunders-Aelen J; Smekens T; Broekhuizen H; D'Alessandro U; Peeters Grietens K
    Malar J; 2021 Apr; 20(1):198. PubMed ID: 33902611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A qualitative study of recruitment barriers, motivators, and community-based strategies for increasing clinical trials participation among rural and urban populations.
    Friedman DB; Foster C; Bergeron CD; Tanner A; Kim SH
    Am J Health Promot; 2015; 29(5):332-8. PubMed ID: 24670073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conducting an ongoing HIV clinical trial during the COVID-19 pandemic in Uganda: a qualitative study of research team and participants' experiences and lessons learnt.
    Muwanguzi PA; Kutyabami P; Osingada CP; Nasuuna EM; Kitutu FE; Ngabirano TD; Nankumbi J; Muhindo R; Kabiri L; Namutebi M; Nabunya R; Kiwanuka N; Sewankambo N
    BMJ Open; 2021 Apr; 11(4):e048825. PubMed ID: 33883157
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A qualitative study to assess community barriers to malaria mass drug administration trials in The Gambia.
    Dial NJ; Ceesay SJ; Gosling RD; D'Alessandro U; Baltzell KA
    Malar J; 2014 Feb; 13():47. PubMed ID: 24495715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial participation among underserved communities: Insights from the Louisiana Community Engagement Alliance.
    Craig LS; Sarpong DF; Peacock EM; Theall KP; Williams L; Al-Dahir S; Davis TC; Arnold CL; Williams A; Fields T; Wilson M; Krousel-Wood M
    Am J Med Sci; 2023 Oct; 366(4):254-262. PubMed ID: 37517691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the COVID-19 Emergency and National Lockdown on Italian Citizens' Economic Concerns, Government Trust, and Health Engagement: Evidence From a Two-Wave Panel Study.
    Graffigna G; Palamenghi L; Savarese M; Castellini G; Barello S
    Milbank Q; 2021 Jun; 99(2):369-392. PubMed ID: 33822424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lupus patient decisions about clinical trial participation: a qualitative evaluation of perceptions, facilitators and barriers.
    Arriens C; Aberle T; Carthen F; Kamp S; Thanou A; Chakravarty E; James JA; Merrill JT; Ogunsanya ME
    Lupus Sci Med; 2020; 7(1):e000360. PubMed ID: 32201595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19).
    Urwyler P; Charitos P; Moser S; Heijnen IAFM; Trendelenburg M; Thoma R; Sumer J; Camacho-Ortiz A; Bacci MR; Huber LC; Stüssi-Helbling M; Albrich WC; Sendi P; Osthoff M
    Trials; 2021 Jan; 22(1):1. PubMed ID: 33397449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Community engagement in the prevention and control of COVID-19: Insights from Vietnam.
    Ha BTT; Ngoc Quang L; Quoc Thanh P; Duc DM; Mirzoev T; Bui TMA
    PLoS One; 2021; 16(9):e0254432. PubMed ID: 34495962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Willingness to take COVID-19 vaccination in low-income countries: Evidence from Ethiopia.
    Strupat C; Shigute Z; Bedi AS; Rieger M
    PLoS One; 2022; 17(3):e0264633. PubMed ID: 35239711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized multicenter clinical trial to evaluate the efficacy of melatonin in the prophylaxis of SARS-CoV-2 infection in high-risk contacts (MeCOVID Trial): A structured summary of a study protocol for a randomised controlled trial.
    García IG; Rodriguez-Rubio M; Mariblanca AR; de Soto LM; García LD; Villatoro JM; Parada JQ; Meseguer ES; Rosales MJ; González J; Arribas JR; Carcas AJ; de la Oliva P; Borobia AM
    Trials; 2020 Jun; 21(1):466. PubMed ID: 32493475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing Black, Indigenous and People of Color participation in clinical trials through community engagement and recruitment goal establishment.
    Andrasik MP; Broder GB; Wallace SE; Chaturvedi R; Michael NL; Bock S; Beyrer C; Oseso L; Aina J; Lucas J; Wilson DR; Kublin JG; Mensah GA
    PLoS One; 2021; 16(10):e0258858. PubMed ID: 34665829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 clinical trials: who is likely to participate and why?
    Fisher KA; Epstein MM; Nguyen N; Fouayzi H; Crawford S; Linas BP; Mazor KM
    J Comp Eff Res; 2024 Aug; 13(8):e230181. PubMed ID: 39045844
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.